Microvision, Inc. (MVIS) · Oct 28, 2026 · Earnings
Beat — Revenue $2.4M vs approximately $2.0M consensus
MicroVision earnings beat revenue expectations and delivered 50% gross margin, but operating losses and cash burn remain substantial despite reaffirmed guidance.
MicroVision is moving from an R&D-heavy lidar developer toward a commercial sensor platform, using the Luminar asset acquisition, IRIS demand, and the MOVIA Pro production launch to convert its backlog into shipped revenue. The prior commercial-growth narrative and $10M–$15M 2026 revenue outlook had already been public, so this quarter mainly tests whether that transition is showing up in the numbers.
| Metric | Q3 2026 | Comparison / expectation |
|---|---|---|
| Revenue | $2.4M | $0.2M Q3 2025; approximately $2.0M consensus |
| Gross margin | 50% | Negative in Q3 2025 |
| Operating expenses | $22.5M | $12.0M Q3 2025; $24.4M first-half quarterly average |
| Net loss | $12.2M / $0.45 per share | $14.2M / $0.72 per share in Q3 2025 |
| Adjusted EBITDA loss | $11.1M | $11.7M Q3 2025 |
| Cash and cash equivalents | $28.9M | $32.4M at December 31, 2025 |
| Cash used in operations | $13.6M | Q3 cash outflow |
| 2026 revenue outlook | $10M–$15M | Reaffirmed |
The commercial ramp is real, and revenue narrowly beats the external bar. Quarterly revenue rose to $2.4 million from $0.2 million a year earlier, versus published estimates near $2 million, making this a genuine revenue beat rather than just favorable year-over-year optics. The company also produced a 50% gross margin after a negative prior-year margin. 〔0〕 〔1〕
But the business is still far from self-funding. Operating expenses climbed to $22.5 million, largely because of Luminar, while the quarter consumed $13.6 million of operating cash despite including a $6.3 million German R&D grant. Cash and equivalents ended at $28.9 million, down from $32.4 million at year-end. That leaves the commercial ramp doing the work before the balance sheet does: with $4.8 million of revenue through nine months, MicroVision needs roughly $5.2 million to $10.2 million in Q4 revenue to reach its reaffirmed full-year range. 〔2〕 〔3〕
Cost control improved, but not enough to change the profitability story yet. Quarterly operating expense was about 7.5% below the first-half average, and adjusted EBITDA loss improved modestly year over year. However, the company still posted a $21.3 million operating loss, while weighted-average shares increased to 27.4 million from 19.7 million a year earlier. The lower per-share loss therefore reflects both improved results and a larger share base, not operating profitability. The company’s stated 2027 cash-burn target of $40 million is directionally important, but it remains forward-looking rather than demonstrated in this quarter.
The guidance message is more confirmation than surprise. MicroVision had already reaffirmed the $10 million–$15 million 2026 revenue range earlier in October, so keeping it unchanged is not a fresh upside signal. The new information is that Q3 revenue cleared the modest consensus bar and margins turned positive, while the company still needs a very large Q4 contribution to deliver even the bottom of its range.
Bottom line: This is a narrow earnings beat that validates the first commercial signs of the Luminar-and-MOVIA strategy, especially on revenue and gross margin. It matters, but the heavy cash burn and large Q4 revenue requirement mean the transition is progressing—not yet financially secure.
Q4 results and 2026 revenue closeout, early 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!